Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testosterone and depression in men.

Revital Amiaz1, Stuart N Seidman

  • 1Chaim Sheba Medical Center, Tel Hashomer, Israel.

Current Opinion in Endocrinology, Diabetes, and Obesity
|April 29, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Xanomeline/trospium and suicide-related events in schizophrenia: An early pharmacovigilance analysis.

Schizophrenia research·2026
Same author

Depressed mood and suicidal thoughts reporting with GLP-1 receptor agonists in type 2 diabetes: A WHO VigiBase study.

Journal of affective disorders·2026
Same author

Intranasal Oxytocin Combined With Social Skills Training for Schizophrenia: An Add-on Randomized Controlled Trial.

Schizophrenia bulletin open·2024
Same author

Distinct homotopic functional connectivity patterns of the amygdalar sub-regions as biomarkers in major depressive disorder.

Journal of affective disorders·2024
Same author

Individuals vary in their overt attention preference for positive images consistently across time and stimulus types.

Scientific reports·2024
Same author

An evaluation of treatment response and remission definitions in adult obsessive-compulsive disorder: A systematic review and individual-patient data meta-analysis.

Journal of psychiatric research·2024
Same journal

EDITORIAL INTRODUCTION.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Exploring the role of parathyroid hormone in sarcopenia: A review.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Normocalcemic primary hyperparathyroidism: an update on diagnostic and management challenges.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Prediabetes before pregnancy: implications for risk stratification and research.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Secondary hyperparathyroidism in chronic kidney disease: update on pathophysiology and new treatment targets.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Revisiting the relationship between weight loss and bone health in people living with obesity: insights from the latest evidence.

Current opinion in endocrinology, diabetes, and obesity·2026
See all related articles

Testosterone levels do not consistently correlate with mood. While not a widespread antidepressant, testosterone may benefit specific groups, including hypogonadal or treatment-resistant men.

Area of Science:

  • Endocrinology
  • Psychiatry
  • Men's Health

Background:

  • Depression is a complex mood disorder with multifactorial causes.
  • Testosterone, a key androgen, plays a role in male physiology and well-being.
  • The relationship between testosterone levels and depressive illness remains an area of ongoing research.

Purpose of the Study:

  • To review and synthesize current scientific literature on the role of testosterone in depressive illness.
  • To examine the impact of endogenous testosterone (hypogonadism) on depression.
  • To evaluate exogenous testosterone as a potential treatment for depression.

Main Methods:

  • Systematic literature review of studies investigating testosterone and depression.
  • Analysis of randomized controlled trials (RCTs) evaluating testosterone's antidepressant effects.

Related Experiment Videos

  • Consideration of observational studies on hypogonadism and mood.

    • Main Results:

    • No consistent association found between general testosterone levels and mood.
    • Evidence suggests hypogonadism may contribute to depression in specific vulnerable populations.
    • Chronic depression can potentially lead to hypogonadism in some men.
    • RCT results are conflicting; testosterone is not broadly effective as an antidepressant.
    • Potential benefits observed in select groups: hypogonadal men, antidepressant-resistant individuals, men with early-onset depression, and HIV-infected men.

    Conclusions:

    • Limited evidence supports a widespread influence of testosterone on mood.
    • Testosterone's role in depression appears specific to certain patient subgroups.
    • Further research is needed to clarify testosterone's therapeutic potential in tailored depression treatment.